Lee Ainslie’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,660
Closed -$1.35M 232
2026
Q1
$1.35M Buy
+15,660
New +$1.41M 0.02% 111
2022
Q1
Sell
-1,307
Closed -$94K 293
2021
Q4
$94K Sell
1,307
-9,226
-88% -$670K ﹤0.01% 222
2021
Q3
$807K Sell
10,533
-410
-4% -$32.9K 0.01% 363
2021
Q2
$848K Buy
+10,943
New +$778K 0.01% 333

Other funds holding GMED

Lee Ainslie's GMED Position: Q2 2026 in Review

Lee Ainslie sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 15,660 shares — an estimated $1.35M sold.

Lee Ainslie first reported a position in GMED in Q2 2021 and held it in 4 quarters. The position peaked at $1.35M in Q1 2026. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Lee Ainslie reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Lee Ainslie sold 15,660 Globus Medical shares in Q2 2026, an estimated $1.35M.
  • Lee Ainslie first reported a position in Globus Medical in Q2 2021 and held it in 4 quarters.
  • Lee Ainslie's Globus Medical position peaked at $1.35M in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.